Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers Journal Article


Authors: Dogan, S.; Shen, R.; Ang, D. C.; Johnson, M. L.; D'Angelo, S. P.; Paik, P. K.; Brzostowski, E. B.; Riely, G. J.; Kris, M. G.; Zakowski, M. F.; Ladanyi, M.
Article Title: Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers
Abstract: Purpose: The molecular epidemiology of most EGFR and KRAS mutations in lung cancer remains unclear. Experimental Design: We genotyped 3,026 lung adenocarcinomas for the major EGFR (exon 19 deletions and L858R) and KRAS (G12, G13) mutations and examined correlations with demographic, clinical, and smoking history data. Results: EGFR mutations were found in 43% of never smokers and in 11% of smokers. KRAS mutations occurred in 34% of smokers and in 6% of never smokers. In patients with smoking histories up to 10 packyears, EGFR predominated over KRAS. Among former smokers with lung cancer, multivariate analysis showed that, independent of pack-years, increasing smoking-free years raise the likelihood of EGFR mutation. Never smokers were more likely than smokers to have KRAS G > A transition mutation (mostly G12D; 58% vs. 20%, P = 0.0001). KRAS G12C, the most common G > T transversion mutation in smokers, was more frequent in women (P=0.007) and these women were younger thanmen with the same mutation (median 65 vs. 69, P = 0.0008) and had smoked less. Conclusions: The distinct types of KRAS mutations in smokers versus never smokers suggest that most KRAS-mutant lung cancers in never smokers are not due to second-hand smoke exposure. The higher frequency of KRAS G12C in women, their younger age, and lesser smoking history together support a heightened susceptibility to tobacco carcinogens. ©2012 AACR.
Journal Title: Clinical Cancer Research
Volume: 18
Issue: 22
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2012-11-15
Start Page: 6169
End Page: 6177
Language: English
DOI: 10.1158/1078-0432.ccr-11-3265
PROVIDER: scopus
PMCID: PMC3500422
PUBMED: 23014527
DOI/URL:
Notes: --- - "Export Date: 3 December 2012" - "CODEN: CCREF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronglai Shen
    204 Shen
  2. Melissa Lynne Johnson
    19 Johnson
  3. Marc Ladanyi
    1326 Ladanyi
  4. Daphne Chua Ang
    14 Ang
  5. Gregory J Riely
    599 Riely
  6. Maureen F Zakowski
    289 Zakowski
  7. Sandra Pierina D'Angelo
    252 D'Angelo
  8. Paul K Paik
    255 Paik
  9. Snjezana Dogan
    187 Dogan
  10. Mark Kris
    869 Kris